{"id":58590,"date":"2015-07-10T20:36:23","date_gmt":"2015-07-11T00:36:23","guid":{"rendered":"https:\/\/rarediseases.org\/nord-issues-statement-on-houses-approval-of-21st-century-cures-initiative\/"},"modified":"2015-07-10T20:36:23","modified_gmt":"2015-07-11T00:36:23","slug":"nord-issues-statement-on-houses-approval-of-21st-century-cures-initiative","status":"publish","type":"post","link":"https:\/\/rarediseases.org\/es\/nord-issues-statement-on-houses-approval-of-21st-century-cures-initiative\/","title":{"rendered":"NORD Issues Statement on House&#8217;s Approval of 21st Century Cures Initiative"},"content":{"rendered":"<p>Washington, D.C. \u2013 July 10, 2015 \u2013 The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on today\u2019s approval by the House of the 21st Century Cures legislative initiative.<\/p>\n<p><em>Today\u2019s passage in the House of the 21st Century Cures (H.R. 6) bill is a huge win for the rare disease community, which actively supported the legislation. By promising mandatory funding for the NIH, strengthening the FDA\u2019s ability to streamline the clinical trials process, and further incentivizing the development of orphan products, 21st Century Cures will help pave the way for developing new cures and treatments, thereby closing the gap for the vast majority of the 7,000 rare diseases that currently have no approved treatment. The legislation positions the U.S. to be the continued international leader in medical product innovation.<\/em><\/p>\n<p><em>NORD congratulates the House, Energy &amp; Commerce Committee and the other groups who worked to help this initiative pass. Today\u2019s vote underscores the bipartisan commitment to move this legislation through the House and we hope the same spirit of collaboration leads to prompt development of similar legislation for consideration by the Senate.<\/em><\/p>\n<p>Peter L. Saltonstall<br \/>\nPresident and CEO, National Organization for Rare Disorders (NORD)<\/p>\n<p style=\"text-align: center;\">###<\/p>\n<p>About the National Organization for Rare Disorders (NORD)\u00ae<br \/>\nEstablished in 1983, the National Organization for Rare Disorders (NORD)\u00ae is the primary nonprofit organization representing all patients and families affected by rare diseases in the U.S. NORD is committed to the identification, treatment and cure of all 7,000 rare diseases that affect 30 million Americans, or 1 in every 10 people. NORD provides programs of advocacy, education, research and patient\/family services to improve the lives of all people living with rare diseases. NORD represents more than 220 disease-specific member organizations and partners with many other organizations in specific causes of importance to the rare disease patient community. Join NORD at www.rarediseases.org\/ and on Twitter at @RareDiseases.<\/p>\n<p>MEDIA CONTACT:<br \/>\nJennifer Huron<br \/>\n(203) 304-7258<br \/>\njhuron@rarediseases.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Washington, D.C. \u2013 July 10, 2015 \u2013 The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on today\u2019s approval &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/rarediseases.org\/es\/nord-issues-statement-on-houses-approval-of-21st-century-cures-initiative\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NORD Issues Statement on House&#8217;s Approval of 21st Century Cures Initiative&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[232],"tags":[387,243],"class_list":["post-58590","post","type-post","status-publish","format-standard","hentry","category-advocacy","tag-21st-century-cures","tag-peter-l-saltonstall"],"acf":[],"_links":{"self":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/comments?post=58590"}],"version-history":[{"count":0,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/posts\/58590\/revisions"}],"wp:attachment":[{"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/media?parent=58590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/categories?post=58590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rarediseases.org\/es\/wp-json\/wp\/v2\/tags?post=58590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}